GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $518,000 | – | 2,390 | +79566.7% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 3 | -99.9% | 0.00% | – |
| Q3 2020 | $493,000 | -72.0% | 5,057 | -64.8% | 0.00% | – |
| Q2 2020 | $1,762,000 | -76.8% | 14,361 | -83.5% | 0.00% | -100.0% |
| Q1 2020 | $7,603,000 | -16.3% | 86,827 | -0.1% | 0.00% | 0.0% |
| Q4 2019 | $9,088,000 | +172.8% | 86,919 | +200.1% | 0.00% | – |
| Q3 2019 | $3,331,000 | -86.7% | 28,959 | -80.0% | 0.00% | -100.0% |
| Q2 2019 | $25,018,000 | +10.2% | 145,122 | +7.8% | 0.00% | 0.0% |
| Q1 2019 | $22,704,000 | +44417.6% | 134,682 | +25456.4% | 0.00% | – |
| Q4 2018 | $51,000 | -99.7% | 527 | -99.5% | 0.00% | -100.0% |
| Q3 2018 | $18,055,000 | +100.7% | 104,520 | +62.1% | 0.00% | +100.0% |
| Q2 2018 | $8,997,000 | -78.7% | 64,476 | -82.8% | 0.00% | -80.0% |
| Q1 2018 | $42,214,000 | -54.6% | 374,669 | -46.8% | 0.01% | -54.5% |
| Q4 2017 | $92,949,000 | +0.7% | 704,105 | -22.6% | 0.01% | 0.0% |
| Q3 2017 | $92,318,000 | -20.2% | 909,627 | -21.1% | 0.01% | -21.4% |
| Q2 2017 | $115,641,000 | -36.2% | 1,153,527 | -23.0% | 0.01% | -39.1% |
| Q1 2017 | $181,279,000 | -5.4% | 1,498,915 | -12.6% | 0.02% | -11.5% |
| Q4 2016 | $191,680,000 | -17.7% | 1,715,265 | -2.3% | 0.03% | -16.1% |
| Q3 2016 | $232,923,000 | +59.0% | 1,754,858 | +9.7% | 0.03% | +55.0% |
| Q2 2016 | $146,489,000 | +9.4% | 1,599,748 | -13.8% | 0.02% | +5.3% |
| Q1 2016 | $133,905,000 | -11.4% | 1,855,928 | -14.7% | 0.02% | -5.0% |
| Q4 2015 | $151,136,000 | -24.0% | 2,176,499 | 0.0% | 0.02% | -28.6% |
| Q3 2015 | $198,867,000 | -25.2% | 2,176,499 | +0.6% | 0.03% | -17.6% |
| Q2 2015 | $265,807,000 | +73.0% | 2,163,847 | +28.3% | 0.03% | +70.0% |
| Q1 2015 | $153,657,000 | +229.2% | 1,686,135 | +144.5% | 0.02% | +233.3% |
| Q4 2014 | $46,674,000 | +7.3% | 689,627 | +28.2% | 0.01% | 0.0% |
| Q3 2014 | $43,492,000 | -47.4% | 537,927 | -30.2% | 0.01% | -45.5% |
| Q2 2014 | $82,713,000 | +72.5% | 770,927 | -4.6% | 0.01% | +57.1% |
| Q1 2014 | $47,960,000 | +165.3% | 807,827 | +85.6% | 0.01% | +133.3% |
| Q4 2013 | $18,079,000 | – | 435,227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|